$Frencken(E28.SI)$ Frencken (E28.SI)
watchlist
Conditional view: cautious in the near term. The share-price momentum is clearly weak and 2026H1 earnings softened, although the balance sheet remains comparatively sound and the valuation is not demanding on a price-to-sales basis.
Latest close (2026-11-10): S$1.78, up 2.89% on the day, but down 12.32% over five trading days, 27.64% over 20 days and 35.51% over 60 days. It sits at only 21.54% of its 52-week range, 49.72% below the 52-week high of S$3.54. This indicates that the one-day rebound has not yet reversed the broader downtrend.
Trading activity: 4.44 million shares traded; volume ratio was 1.04, close to normal rather than a decisive high-volume reversal.
Frencken
1.78
0.05
+0.05(2.89%)
Nov 10 17:16 SGT
Fundamentals
Metric 2026H1 YoY change
Revenue S$427.8m -0.83%
Operating income S$23.6m +7.39%
Net income S$19.3m -3.36%
EPS S$0.0450 -3.56%
The key mixed signal is that first-half revenue and net profit declined modestly, while operating income rose. That suggests cost or operating-margin improvement partly offset weaker sales, but the improvement had not translated into higher bottom-line earnings.
For 2025FY, revenue grew 8.91% to S$865.1m and net income rose 5.39% to S$39.1m. However, 2026H1 shows that this growth pace has stalled, which is likely the central issue investors will watch in the next results.
Financial quality and valuation
TTM P/E: 19.78x
P/B: 1.73x
P/S: 0.98x
ROE: 8.31%; ROA: 3.81%
Dividend yield: 1.54%; latest indicated dividend was S$0.0275 per share.
At 2026H1, the debt ratio was 37.46%, while the current ratio was 2.46x and quick ratio 1.43x. Liquidity therefore appears adequate despite the lower earnings growth.
The valuation is not obviously distressed: the P/E near 20x requires an eventual return to earnings growth, while the P/S below 1x and P/B below 2x provide some balance-sheet support. The dividend yield is modest rather than the primary investment case.
What could change the view
Constructive case: A return to revenue growth, while preserving the 2026H1 operating-income improvement, would support a reassessment after the sharp 60-day share-price decline. News coverage in September reported a S$100m placement intended to fund longer-term strategic investment or acquisitions; this could expand capabilities, but the benefit depends on execution and eventual returns on capital.
Tiger News
Risk case: Continued revenue contraction, further weakening of net profit/cash conversion, or dilution/poor capital deployment from expansion initiatives could keep pressure on the shares. The stock’s large decline from its 52-week high also means sentiment may remain fragile until reported results improve.
What to monitor: the next revenue trend, net margin versus the 2026H1 level, operating cash flow, and any concrete use of the S$100m funding. No current analyst-consensus target or rating data was available.
Information is for reference only and does not constitute investment advice.| Side | Price | Filled | Realized P&L |
|---|
| Buy Open | 1.77 1,000 | +0.57% Holding |
FrenckenDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.